相关实验视频
Updated: May 22, 2025

05:16
Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
6.5K
肥胖型2型糖尿病患者的血糖控制,这些患者接受了 laparoscopic 袖子胃切除术和过境双分割治疗
1Department of General Surgery, Muğla Sıtkı Koçman University, Muğla, Turkey.
概括
通过过渡双分割 (LSG+TB) 进行 laparoscopic 袖子胃切除术,有效地管理2型糖尿病 (T2DM) 和肥胖症. 在T2DM患者中,与 pylorus 距离 6 厘米的紧固件线距离会产生卓越的血糖控制改善.
科学领域:
- 腹部外科 腹部外科
- 代谢手术 代谢手术
- 内分泌学 在内分泌学.
背景情况:
- 二型糖尿病 (T2DM) 和肥胖是全球主要的健康问题.
- 用过渡双分割 (LSG+TB) 进行 laparoscopic 袖子胃切除术是对T2DM和肥胖症的一种有前途的手术干预.
- 优化LSG+TB手术技术对于患者的治疗结果至关重要.
研究的目的:
- 评估LSG+TB在患有T2DM的肥胖患者中的疗效.
- 研究外科手术技术变化对血糖控制的影响.
- 为了确定LSG+TB的最佳手术参数.
主要方法:
- 对420名肥胖T2DM患者进行了回顾性分析,这些患者接受了LSG+TB.
- 数据收集包括手术前/手术后的HbA1c,BMI和手术细节.
- 评估HbA1c在3个月和12个月的变化,基于接线距离,常见通道长度和动静脉环直径.
主要成果:
- 与8厘米和10厘米的距离相比,6厘米的接线距离与显著更大的HbA1c降低有关 (P=0.019).
- 一年后的平均体重减轻率为68.11%.
- 常见的通道长度和动静脉环直径没有显著影响HbA1c水平.
结论:
- LSG+TB是一种有效的治疗方法,可以改善肥胖T2DM患者的血糖控制.
- 从 pylorus 距离 6 厘米的接线距离与优越的 HbA1c 降低和可比的安全性有关.
- 进一步的研究可能会完善LSG+TB技术,以加强T2DM管理.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Carbohydrate Metabolism
10.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.7K
Diabetes: Management and Pharmacotherapy
220
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
220
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
38
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
38
Glucagon-like Receptor Agonists
281
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
281
Insulin: Dosing Regimen and Adverse Effects
135
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
135

